Advances in antiretroviral therapy. Highlights of the 11th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2004, San Francisco, California, USA.
Antiretroviral therapy was focus of many of the studies reported at the 11th CROI. This year, data on new drugs, refinements in the management of treatment-naive and treatment-experienced persons, the impact of drug resistance (particularly following exposure to a single dose of nevirapine), and the growing experience with antiretrovirals in the developing world were the dominant themes. This reviews summarizes new information relevant to clinicians and clinical researchers.
Sobieszczyk
Magdalena E
ME
Columbia University College of Physicians and Surgeons, New York, NY, USA.
Coakley
Eoin P G
EP
Wilkin
Timothy J
TJ
Hammer
Scott M
SM
D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D015507:Drugs, Investigational; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans
D044966:Anti-Retroviral Agents; D015507:Drugs, Investigational